ANDHealth ACTIVATE
AcceleratorMelbourne · Pre-Seed–Series A · 20 people tracked
Investment thesis
ANDHealth focuses on accelerating the commercialisation of evidence-based digital and connected health technologies in Australia. Through flagship programs such as ANDHealth+, CUREator+ and ACTIVATE, it delivers government- and privately-funded non-dilutive investment, investment readiness support, education, mentorship and events to early-stage digital health startups. The organisation manages over A$30M in public and private commitments and provides specialist support to further funding managed by Brandon Capital, deploying capital across portfolio companies and supporting a large pipeline of SMEs to de-risk technologies and strengthen investor and market readiness.
Source: firm website, verified Aug 2, 2026.
Team · 20 people
from the firm's websiteFounder of ANDHealth (2017) with over 20 years of executive experience in health technology commercialisation, venture capital and capital raising. She is a Member of the Council of the NHMRC and a Non-Executive Director of Lumos Diagnostics.
Commercialisation professional and fund program leader who runs ANDHealth's $33M+ MRFF-funded ANDHealth+ program and co-manages the CUREator+ programs, overseeing cohort selection, due diligence and portfolio strategy.
Over 30 years in health, medical research and policy, previously a leader in commercialisation at NSW Health where she designed the NSW Medical Devices Fund. Awarded a Public Service Medal in 2025 and is a Fellow of the Australian Academy of Technological Sciences and Engineering.
Health and medical research policy leader with over 30 years' experience, previously at NSW Health where she designed programs including the NSW Medical Devices Fund. Awarded the Public Service Medal in 2025.
Communications and marketing director who joined ANDHealth in 2021, leading strategic communications, social media, digital campaigns and event marketing.
Investor, adviser and entrepreneur in innovation and commercialisation, former inaugural CEO of the Office of Innovation and Science Australia and co-founder of the Melbourne Accelerator Program.
Finance and governance professional with over 25 years' experience providing company secretarial and CFO services across digital health, life sciences and biotech. Chartered Accountant and Fellow of the Governance Institute of Australia.
Non-Executive Chair of ANDHealth with a 40-year career in medical technology across Australia/NZ and Asia, formerly Managing Director ANZ and VP Asia Pacific at Johnson & Johnson Medical Devices.
Medtech commercialisation leader with over eight years' experience, Co-Founder and COO of Seer Medical (2017-2024), which she helped grow to 220 staff across three countries with TGA, CE and FDA approvals.
Events and stakeholder engagement professional with over 15 years in life sciences, previously at AusBiotech supporting investment attraction and sector programs.
Joined ANDHealth in 2024 with over seven years in healthtech; leads CHICC and national events, previously Events and Projects Manager at BioMelbourne Network.
Joined ANDHealth in 2024 with over seven years in healthtech; leads CHICC and national events, previously Events and Projects Manager at BioMelbourne Network and a former resource geologist.
Healthcare information sector leader with over 25 years' experience and Group Managing Director of ASX-listed health technology company Alcidion.
Strategic and crisis communications professional with over 20 years' experience, formerly a Managing Director at Teneo in Dubai and adviser to Prime Ministers in Australia and New Zealand.
Biomedical engineer, data analyst and tech founder with experience in medical technology, human anatomy and clinical research, skilled in Python programming and data pipeline development.
Chief of Staff supporting the CEO on strategic initiatives, previously Portfolio Manager and Lead Analyst who managed deployment of over $8M across five portfolio companies in ANDHealth's non-dilutive investment programs.
Finance and corporate services leader with over 35 years' experience across chartered accounting, government and not-for-profit boards, most recently leading VicHealth's organisational transformation.
Experienced Chair and Non-Executive Director across biotech and health technology, former Deloitte Australia partner of 23 years, currently Chair of Neurizon Therapeutics.
Program Director leading LaunchVic-funded initiatives supporting early-stage digital health startups, with over five years of program management experience.
Innovation professional focused on the convergence of technology, life science and health, with experience building health ventures across Australia and Sweden spanning AI diagnostics, regenerative medicine and medical devices.
Frequently asked questions
- What stage does ANDHealth ACTIVATE invest at?
- ANDHealth ACTIVATE invests at the Pre-Seed, Seed, Series A stages.
- What sectors does ANDHealth ACTIVATE focus on?
- ANDHealth ACTIVATE focuses on Digital Health, Healthtech, Medical Devices.
- Where is ANDHealth ACTIVATE located?
- ANDHealth ACTIVATE is headquartered in Melbourne, AU.
Media · Podcasts & interviews
from their channel🚀 Supercharge your startup with ANDHealth ACTIVATE
ANDHealth
The remarkable impact of ANDHealth+
ANDHealth
Hear how ACTIVATE, supported by LaunchVic, helped Virtetic take the company to the next level
ANDHealth
Hear how ACTIVATE, supported by LaunchVic, helped SmartHeal take the company to the next level
ANDHealth
Hear how ACTIVATE, supported by LaunchVic, helped Humanetix take the company to the next level
ANDHealth
Similar investors
Amadeus Capital Partners is a technology investor. It held a first close of $75M on its Amadeus IV Digital Prosperity Fund, focused on late-stage venture and growth companies building online and mobile services for emerging-market middle classes.
B Capital Group is a multistage venture capital firm that invests from seed to late stage, offering value-added support to founders in partnership with management consulting firm BCG.
Breyer Capital is a venture capital firm founded and led by Jim Breyer, headquartered in Austin, Texas, focused on long-term entrepreneurs in AI, quantum technology, and computation-driven healthcare and life sciences.
DCVC (Data Collective) is a deep tech venture capital firm backing entrepreneurs using computational approaches to solve large real-world problems across many industries. It operates six flagship funds plus DCVC Bio, spanning 13 funds to date.
Innovestor is a Finland-based investment group active in venture capital, life science and health, technology, real estate, and energy storage, also offering angel co-investment and corporate venturing services.